Immunitybio (IBRX) had the highest return between October 8, 2019 and January 31, 2020 by a mid-cap US stock, returning 418%.
Immunitybio (IBRX) had the highest return between October 8, 2019 and January 31, 2020 by a mid-cap US stock, returning 418%.
Mid-cap stocks are treated as having a market cap between $2B and $10B.